Immunocore Holdings plc ( IMCR) - Key Metrics
IMCR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.27 | -$0.02 | -$0.11 | -$0.12 |
| 2026Q1 | $2.10 | $0.26 | -$0.27 | -$0.31 |
| 2025Q4 | $1.54 | -$0.44 | -$0.65 | -$0.71 |
| 2025Q3 | $2.06 | $0.02 | -$0.09 | -$0.10 |
| 2025Q2 | $1.95 | -$0.20 | $0.52 | $0.51 |
IMCR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -396.88 |
| 2026Q1 | 0% | 28.99 |
| 2025Q4 | 0% | -19.72 |
| 2025Q3 | 0% | 582.21 |
| 2025Q2 | 0% | -37.36 |
IMCR
Price: $34.21
52 week price:
Earnings Per Share: -0.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 522338
Market Capitalization: 1.8 billion